Rare diseases
Investigational molecules
Locations
1 Avenue Irene Joliot Curie, 31100 Toulouse, France
Clinical research includes treatment strategies for recurrent glioblastoma, with interest in combining stereotactic radiotherapy and immunotherapy to address aggressive central nervous system disease.
The sponsor also supports work in pediatric neuroblastoma, including peptide receptor radionuclide therapy for recurrent or refractory disease.
Oncopole Claudius Regaud runs clinical trials in conditions such as Breast cancer metastatic, Squamous cell carcinoma of head and neck, Soft tissue sarcoma, Neuroblastoma, among others.
Clinical trials run by this sponsor – those enrolling participants first.
FranceFranceFranceFranceFranceFranceFranceIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
